Literature DB >> 22783966

Racial/ethnic differences in health status and morbidity among adults who use methamphetamine.

Diane M Herbeck1, Mary-Lynn Brecht, Aurora Z Pham.   

Abstract

Higher disease rates among ethnic-minority populations compared to Whites have been pervasive and persistent over time, and as methamphetamine (MA) use continues to penetrate ethnically diverse geographic regions across the United States, minority populations may be at increased risk for adverse MA-related health consequences, thus further contributing to poorer health among vulnerable populations. This study examines racial/ethnic differences in health status and health conditions among individuals who used MA. Data are from a natural history interview study of adult MA users (N = 512), half of whom received treatment for MA abuse, and a comparison group who had not received substance abuse treatment. Chi-square and logistic regression analyses examined differences by race/ethnicity in self-reported health status and morbidity, adjusting for age, gender, and health behaviors including MA use severity and tobacco use. Overall, back/neck injuries (27%), severe dental problems (26%), gunshot/knife injury (25%), and sexually transmitted diseases (STDs) (24%) were commonly reported. Racial/ethnic differences were observed for conditions including gunshot/knife injuries, hearing loss, and learning disabilities disproportionately affecting Latino populations, and asthma and STDs disproportionately affecting African-Americans. Results varied by whether treatment for MA abuse was received. Although poor health and morbidity were common overall, each ethnic group may be at higher risk for specific health problems. Health status and conditions in this MA-using sample are examined and discussed with reference to general population data. These findings may assist researchers and treatment providers in addressing health consequences of the increasing prevalence of MA use among minority populations. Understanding ethnic differences in health status among MA users may assist in developing interventions to target specific health care needs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783966      PMCID: PMC3644375          DOI: 10.1080/13548506.2012.701754

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  20 in total

1.  Self-reported health status among treated methamphetamine users.

Authors:  Lisa Greenwell; Mary-Lynn Brecht
Journal:  Am J Drug Alcohol Abuse       Date:  2003       Impact factor: 3.829

2.  The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients.

Authors:  Jennifer R Mertens; Alan J Flisher; Derek D Satre; Constance M Weisner
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

3.  Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the U.S. population in care.

Authors:  William E Cunningham; Nancy L Sohler; Carol Tobias; Mari-lynn Drainoni; Judith Bradford; Cynthia Davis; Howard J Cabral; Chinazo O Cunningham; Lois Eldred; Mitchell D Wong
Journal:  Med Care       Date:  2006-11       Impact factor: 2.983

4.  Life expectancies for individuals with psychiatric diagnoses.

Authors:  H Hannerz; P Borgå; M Borritz
Journal:  Public Health       Date:  2001-09       Impact factor: 2.427

5.  Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).

Authors:  Mary-Lynn Brecht; Lisa Greenwell; M Douglas Anglin
Journal:  J Subst Abuse Treat       Date:  2005-12

Review 6.  Implications of chronic methamphetamine use: a literature review.

Authors:  Charles W Meredith; Craig Jaffe; Kathleen Ang-Lee; Andrew J Saxon
Journal:  Harv Rev Psychiatry       Date:  2005 May-Jun       Impact factor: 3.732

7.  Methamphetamine use behaviors and gender differences.

Authors:  Mary-Lynn Brecht; Ann O'Brien; Christina von Mayrhauser; M Douglas Anglin
Journal:  Addict Behav       Date:  2004-01       Impact factor: 3.913

8.  Burden of medical illness in drug- and alcohol-dependent persons without primary care.

Authors:  Israel De Alba; Jeffrey H Samet; Richard Saitz
Journal:  Am J Addict       Date:  2004 Jan-Feb

Review 9.  The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.

Authors:  Jane Carlisle Maxwell; Beth A Rutkowski
Journal:  Drug Alcohol Rev       Date:  2008-05

10.  Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.

Authors:  Jennifer R Mertens; Yun W Lu; Sujaya Parthasarathy; Charles Moore; Constance M Weisner
Journal:  Arch Intern Med       Date:  2003-11-10
View more
  7 in total

1.  Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention.

Authors:  Katherine Sanchez; T L Greer; R Walker; T Carmody; C D Rethorst; M H Trivedi
Journal:  J Ethn Subst Abuse       Date:  2017-05-19       Impact factor: 1.507

2.  Mortality, causes of death, and health status among methamphetamine users.

Authors:  Diane M Herbeck; Mary-Lynn Brecht; Katherine Lovinger
Journal:  J Addict Dis       Date:  2014-11-21

3.  A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.

Authors:  LaTrice Montgomery; Ann Kathleen Burlew; Angela M Haeny; Chizara A Jones
Journal:  Psychol Addict Behav       Date:  2019-06-27

4.  Minorities and foreign born are disproportionately affected by injuries due to violence: an analysis based on a National Trauma Registry 2008-2017.

Authors:  Abebe Tiruneh; Irina Radomislensky; Kobi Peleg; Maya Siman-Tov
Journal:  Isr J Health Policy Res       Date:  2019-03-07

5.  Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis.

Authors:  Li He; Yanhui Liao; Qiuxia Wu; Tieqiao Liu
Journal:  Front Psychiatry       Date:  2020-11-19       Impact factor: 4.157

6.  Racial identity as a moderator of the association between socioeconomic status and quality of life.

Authors:  Adekunle Adedeji; Johanna Buchcik; Tosin Yinka Akintunde; Erhabor S Idemudia
Journal:  Front Sociol       Date:  2022-08-11

Review 7.  An animal model of differential genetic risk for methamphetamine intake.

Authors:  Tamara J Phillips; Shkelzen Shabani
Journal:  Front Neurosci       Date:  2015-09-23       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.